New medication may reduce chances of a second clot-caused stroke without bleeding risk
An investigational anti-clotting medication, asundexian, has demonstrated a reduction in the risk of a second ischemic (clot-caused) stroke without raising bleeding concerns, according to a preliminary late-breaking science ...
Feb 5, 2026
0
0








